OB COMPLETE PETITE- calcium ascorbate, cholecalciferol, .alpha.-tocopherol acetate, d-, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, folic acid, cyanocobalamin, iron, ferrous asparto glycinate, zinc oxide, cupric sulfate, and doconexent capsule, liquid filled 
Vertical Pharmaceuticals, LLC

----------

OB Complete® Petite

SUPPLEMENT FACTS

Supplement Facts box

Other Ingredients: Soybean Oil, Yellow Bees Wax, Lecithin, Gelatin, Purified Water, Titanium Dioxide, FD&C Red #40, Ethyl Vanillin, FD&C Blue #1.

CONTAINS: SOY AND FISH OIL (ANCHOVY)

 

GLUTEN-, LACTOSE-, AND SUGAR-FREE

OB Complete® Petite is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers.

CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNINGS

 WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.

KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.

DRUG INTERACTIONS

OB Complete®Petite softgel capsules are not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine.  There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, Clopidogrel).

ADVERSE REACTIONS

Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.

DESCRIPTION

OB Complete® Petite is an oval-shaped plum colored softgel capsule, imprinted "VP 059".

DIRECTIONS FOR USE

One softgel capsule daily or as directed by a physician.

HOW SUPPLIED

OB Complete® Petite is supplied in a 30 count child-resistant bottle.

Product Code: 68025-059-30

STORAGE

Store at controlled room temperature 15°-30°C (59°-86°F) [See USP]. Protect from light, moisture and excessive heat.

KEEP OUT OF REACH OF CHILDREN.

 PATENTED FORMULA.  U.S. PAT. No. 8,263,137

For use on the order of a healthcare practitioner.

Call your doctor about side effects. To report side effects, call Vertical Pharmaceuticals at 1-770-509-4500 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Distributed by:

Vertical Pharmaceuticals, LLC

Alpharetta, GA 30005

www.OBComplete.com

PLR-OBCPT-00005-2                       Rev. 11/2021

**Ferrous Asparto Glycinate (Sumalate®, a registered trademark of Albion International, Inc.) is covered by the following patents:

U.S. Pat. No. 6,716,814, U.S. Pat. No. 8,007,846 and U.S. Pat. No. 8,425,956.

vERTICAL LOGO

PRINCIPAL DISPLAY PANEL - 30 Capsule Bottle Label

68025-059-30

OB
COMPLETE
®

Petite

Gluten,
Lactose and
Sugar-Free

VERTICAL
PHARMACEUTICALS, LLC

30 SOFTGEL
CAPSULES

 

OB Complete Petite Trade Label Rev. 112021
OB COMPLETE PETITE 
calcium ascorbate, cholecalciferol, .alpha.-tocopherol acetate, d-, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, folic acid, cyanocobalamin, iron, ferrous asparto glycinate, zinc oxide, cupric sulfate, and doconexent capsule, liquid filled
Product Information
Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:68025-059
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CALCIUM ASCORBATE (UNII: 183E4W213W) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID75 mg
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL1000 [iU]
.ALPHA.-TOCOPHEROL ACETATE, D- (UNII: A7E6112E4N) (.ALPHA.-TOCOPHEROL, D- - UNII:N9PR3490H9) .ALPHA.-TOCOPHEROL, D-30 [iU]
THIAMINE MONONITRATE (UNII: 8K0I04919X) (Thiamine ION - UNII:4ABT0J945J) THIAMINE2 mg
RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR) RIBOFLAVIN3.4 mg
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE HYDROCHLORIDE30 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1 mg
CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN15 ug
IRON (UNII: E1UOL152H7) (IRON - UNII:E1UOL152H7) IRON35 mg
FERROUS ASPARTO GLYCINATE (UNII: H7426RGB3L) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION5 mg
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE25 mg
CUPRIC SULFATE (UNII: LRX7AJ16DT) (CUPRIC CATION - UNII:8CBV67279L) CUPRIC CATION1 mg
DOCONEXENT (UNII: ZAD9OKH9JC) (DOCONEXENT - UNII:ZAD9OKH9JC) DOCONEXENT200 mg
Inactive Ingredients
Ingredient NameStrength
SOYBEAN OIL (UNII: 241ATL177A)  
YELLOW WAX (UNII: 2ZA36H0S2V)  
LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
GELATIN (UNII: 2G86QN327L)  
WATER (UNII: 059QF0KO0R)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
ETHYL VANILLIN (UNII: YC9ST449YJ)  
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NHRIC:68025-059-3030 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
DIETARY SUPPLEMENT10/26/2012
Supplement Facts
Serving Size : Serving per Container :
Amount Per Serving% Daily Value
color
imprint
scoring1
shape
size (solid drugs)15 mm
Labeler - Vertical Pharmaceuticals, LLC (173169017)

Revised: 11/2021
Document Id: 3f25face-0372-49d0-9722-9b624fe08389
Set id: 6bffb66f-6b1b-44e2-ba4d-211091e99ef7
Version: 8
Effective Time: 20211124
 
Vertical Pharmaceuticals, LLC